Metlife INC Form 4 insider transactions

NYSE
MetLife Inc. director Christian Stephane Mumenthaler acquired 20 shares of common stock through a dividend reinvestment plan on June 9, 2026.
NYSE
MetLife, Inc. Director Daniel S. Glaser reported transactions involving common stock, including dividend reinvestment and shares held in a GRAT.
NYSE
MetLife, Inc. Director Robert Glenn Hubbard acquired company common stock through a dividend reinvestment plan.
NYSE
MetLife Inc. executive Ramy Tadros reported a transaction involving the reinvestment of dividends on deferred shares.
NYSE
Marlene Debel, EVP & Chief Risk Officer at MetLife, Inc., reported transactions involving the acquisition and disposition of company stock and employee stock options.
NYSE
Adrienne O'Neill, EVP & Chief Accounting Officer at MetLife, Inc., reported the acquisition of 12,485 shares of common stock via a restricted stock unit award.
NYSE
Carla A. Harris, a Director at MetLife Inc., acquired 721 shares of common stock on April 1, 2026, as part of the company's non-management director compensation plan.
NYSE
MetLife, Inc. director Michelle Seitz received common stock as part of her compensation, according to a Form 4 filing.
NYSE
MetLife, Inc. director William E. Kennard acquired company common stock as part of director compensation and also holds shares indirectly through a policyholder trust.
NYSE
Robert Glenn Hubbard, a Director at MetLife Inc., acquired 1,248 shares of common stock on April 1, 2026, as part of the company's non-management director compensation plan.
NYSE
MetLife, Inc. reports that Director Denise M. Morrison acquired 721 shares of common stock on April 1, 2026, as part of the company's non-management director compensation plan.
NYSE
MetLife, Inc. director Christian Stephane Mumenthaler acquired common stock valued at $71.17 per share as part of the company's non-management director compensation program.
NYSE
MetLife, Inc. reports that Director Laura J. Hay acquired company common stock as part of her compensation.
NYSE
Diana McKenzie, a Director at MetLife Inc., acquired 721 shares of common stock on April 1, 2026, as part of the company's non-management director compensation plan.
NYSE
Daniel S. Glaser, a Director at MetLife Inc., reported transactions involving the acquisition of common stock and holdings in a GRAT.
NYSE
Carlos M. Gutierrez, a Director at MetLife Inc., reported the acquisition of 721 shares of common stock on April 1, 2026, as part of the company's non-management director compensation plan.
NYSE
Mark A. Weinberger, a Director at MetLife Inc., received an award of 721 shares of common stock on April 1, 2026, as part of the company's non-management director compensation plan.
NYSE
MetLife, Inc. Director Jeh C. Johnson acquired 721 shares of common stock through a deferred compensation plan.
NYSE
MetLife Director Daniel S. Glaser reported an acquisition of 273 common shares and reclassified 198 shares held in a GRAT.
NYSE
MetLife Director Diana McKenzie acquired 189 shares of common stock through dividend reinvestment, bringing her total direct beneficial ownership to 23,751 shares.
NYSE
MetLife Director Jeh C. Johnson acquired 65 shares of common stock through dividend reinvestment, increasing total beneficial ownership to 8,129 shares.
NYSE
MetLife Director Christian Mumenthaler acquired 17 shares of common stock through dividend reinvestment, increasing his direct beneficial ownership to 2,125 shares.
NYSE
MetLife Director Carla A Harris increased her beneficial ownership by 43 shares through a dividend reinvestment plan.
NYSE
MetLife's EVP & CFO, John D. McCallion, disposed of 6,985 shares of common stock to cover tax obligations related to restricted stock units.
NYSE
MetLife's EVP & Chief HR Officer, Shurawl Sibblies, reported a routine disposition of 220 common shares for tax withholding purposes related to restricted stock units.
NYSE
MetLife's EVP & Chief Risk Officer, Marlene Debel, disposed of 4,133 common shares to cover tax obligations related to restricted stock units.
NYSE
MetLife's President and CEO, Michel Khalaf, disposed of 22,420 shares of common stock to cover tax obligations related to restricted stock units.
NYSE
MetLife's EVP of Global Technology & Operations, Bill Pappas, reported a routine disposition of 5,989 common shares to cover tax obligations related to restricted stock unit vesting.
NYSE
MetLife's President of U.S. Business, Ramy Tadros, disposed of 5,166 shares of common stock at $73.24 per share to cover tax obligations related to restricted stock units.
NYSE
MetLife's EVP & Chief Legal Officer, Monica M. Curtis, disposed of 953 shares of common stock to cover tax liabilities related to restricted stock units.